It's a short question for Mr. Stratton. You mention in recommendation 17 that the federal government should not look to duplicate work already being done by insurers for a national pharmacare plan. Of course, the Parliamentary Budget Officer actually says that businesses would save about $6 billion and that overall, as Canadians, we'd save $4 billion with a national pharmacare plan. I'm a bit concerned, then, about the idea of not duplicating, because it actually adds to costs.
Is the Canadian Chamber of Commerce opposed to a national pharmacare plan that is universal?